Thymosin Alpha-1 20mg — Vial Spec, Reconstitution Math & COA

Overview of Thymosin Alpha-1 20mg Vial Configuration & Lab Availability

In experimental biology and cellular research, Thymosin Alpha-1 (Tα1) is frequently investigated for its role in modulating signal transduction pathways, gene expression, and cellular immune responses in vitro. A 20mg vial configuration contains 20 milligrams of highly purified, vacuum-dried lyophilized powder composed of the 28-amino acid N-acetylated peptide sequence. This mass density is specifically favored by high-volume research facilities conducting parallel assays, multi-well cell culture exposures, or structural analysis via spectroscopy where consistent working solution concentrations must be derived from a single analytical lot.

While PX1 Research features standard catalog sizes such as our Thymosin Alpha-1 5mg vial, understanding the operational parameters of a 20mg specification is critical for principal investigators planning large-scale laboratory workflows. For specialized high-throughput projects, purchasing high-mass vials or arranging custom bulk production allows laboratories to minimize lot-to-lot variance across extended timelines. Researchers searching our primary catalog of all peptides can evaluate baseline chemical attributes, purity metrics, and availability across multiple unit sizes to align with specific experimental designs.

Molecular Properties and Sequence Specifications

Thymosin Alpha-1 is a synthetically produced 28-amino acid peptide corresponding to the naturally occurring sequence purified from thymic tissue. Chemically designated with an N-terminal acetylation, its primary structure is represented as Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH. It possesses a empirical molecular formula of C129H215N33O55 and an exact molecular weight of approximately 3108.3 Da.

Preclinical studies suggest that the physiological active peptide interacts directly with Toll-like receptors (specifically TLR2 and TLR9) in dendritic cell cultures and macrophages, initiating downstream activation of nuclear factor kappa B (NF-κB) and p38 mitogen-activated protein kinase (MAPK) pathways. In vitro data indicate that these interactions alter cytokine production profiles, upregulating expressions of interleukin-2 (IL-2) and interferon-gamma (IFN-γ). Understanding these specific molecular weights and terminal modifications is vital for researchers calculating molar concentrations in biochemical kinetic assays.

Volumetric Reconstitution Math for a 20mg Lyophilized Cake

Reconstituting a 20mg vial requires precise liquid handling calculations to achieve exact target working concentrations. Because a 20mg cake contains four times the peptide mass of a standard 5mg vial, researchers must adjust diluent volumes accordingly to avoid over-concentration or volumetric pipetting errors. The choice of diluent—typically sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use analytical storage or unpreserved Sterile 0.9% Sodium Chloride / Water for Injection for sensitive cell cultures—depends entirely on the end-use assay environment.

To calculate working concentrations, apply the formula: Concentration (mg/mL) = Total Mass (mg) / Volume Added (mL). For a 20mg vial, common diluent additions yield the following baseline working concentrations:

1.0 mL Diluent Addition: Yields a concentration of 20 mg/mL (20 µg/µL). This hyper-dense stock is ideal for minimizing the volume added to liquid culture media, ensuring that solvent or vehicle percentages remain below critical thresholds in cell viability assays.

2.0 mL Diluent Addition: Yields a concentration of 10 mg/mL (10 µg/µL). This provides a highly workable decimal concentration that simplifies serial dilution math across 96-well plate treatments.

3.0 mL Diluent Addition: Yields a concentration of 6.67 mg/mL (6.67 µg/µL). This lower density is well-suited for automated liquid handling systems that require larger minimal dead volumes in reservoir channels.

To rapidly verify volumetric math across varying vial masses and diluent volumes, researchers can utilize our integrated reconstitution calculator to ensure accurate laboratory dosing parameters.

Aliquot Planning and Storage Protocols to Prevent Degradation

Once a 20mg Thymosin Alpha-1 vial is reconstituted, the peptide in solution becomes susceptible to chemical degradation via hydrolysis, oxidation, and aggregation over time. Repeated freeze-thaw cycles significantly accelerate peptide backbone cleavage and loss of tertiary structure. Therefore, high-yield vials require a strict aliquot protocol immediately following complete dissolution.

Investigators should divide the master reconstituted solution into single-use micro-aliquots (e.g., 50 µL to 100 µL) in sterile, polypropylene microcentrifuge tubes. Freezing these sub-lots at -20°C or -80°C preserves structural stability for extended periods. When an assay is scheduled, only the required aliquot is thawed, brought to room temperature, and used entirely, eliminating cyclic thermal stress on the remaining inventory. Standard refrigerated storage at 2°C to 8°C for reconstituted Tα1 should strictly be limited to short-term working windows (typically under 14 to 28 days when preserved with bacteriostatic agents).

Quality Verification: Reading the Lot-Matched COA

Every research compound supplied by PX1 Research undergoes rigorous, lot-specific analytical verification before release. Every batch is issued a comprehensive certificate of analysis that documents the exact identity, purity, and physical parameters of the enclosed peptide mass. When reviewing a COA for a 20mg Thymosin Alpha-1 lot, researchers should inspect two critical high-performance metrics: High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS).

The HPLC chromatogram measures chemical purity by separating the primary peptide peak from synthesis byproducts, truncated sequences, or residual protecting groups. PX1 maintains a strict baseline standard of ≥98.0% purity by HPLC area normalization. Concurrently, Mass Spectrometry (typically ESI-MS or MALDI-TOF) verifies the exact molecular mass of the principal peak, confirming that the observed mass-to-charge ratio matches the theoretical molecular weight of 3108.3 Da. This dual-verification framework guarantees that experimental variations are driven solely by biological parameters rather than chemical impurities.

Endotoxin Testing & GMP-Compliant Manufacturing Standards

For research involving delicate primary cell lines, immune cell cultures, or sensitive target receptors, biological contaminants like bacterial endotoxins (lipopolysaccharides) can invalidate experimental outcomes by stimulating non-specific inflammatory pathways. High-mass vials like the 20mg specification require specialized manufacturing controls to prevent concentration of residual pyrogens during the lyophilization phase.

PX1 Research compounds are manufactured in ISO 17025 accredited, GMP-compliant facilities. Every lot undergoes strict Limulus Amebocyte Lysate (LAL) endotoxin testing to ensure pyrogen levels remain strictly below threshold specifications (<0.1 EU/mg). This rigorous standard prevents false-positive activation of TLR pathways in vitro, ensuring that observed cellular responses are directly attributable to the synthetic Thymosin Alpha-1 peptide sequence.

Selecting the Optimal Format: 20mg vs. 5mg Vials in Research Workflows

Determining whether to acquire a 20mg vial format or smaller specifications like the Thymosin Alpha-1 5mg vial depends entirely on the scale and duration of the planned experimental protocol. Smaller formats are highly advantageous for pilot studies, exploratory benchwork, or assays conducted sporadically, as they reduce the financial loss associated with unused reconstituted material that expires in solution.

Conversely, a 20mg vial is optimal for automated liquid handling workstations, long-term continuous culture studies, and multi-investigator projects. Utilizing a single 20mg vial across an entire trial phase eliminates inter-vial reconstitution variability, ensuring consistent baseline concentration across hundreds of experimental wells. For high-volume research institutions planning high-throughput runs, setting up a bulk institutional account via our wholesale portal provides specialized sourcing support and coordinated batch-lot reservations.

Comparative Analysis: Tα1 and Related Immunomodulatory Research Compounds

When designing comparative cell signal studies, researchers frequently evaluate Thymosin Alpha-1 alongside other prominent peptides involved in cellular repair, tissue regeneration, and structural defense. Understanding structural and biological differences across these compounds is essential for establishing proper negative and positive controls in experimental models.

For instance, Thymosin Beta-4 is a 43-amino acid peptide primary known in preclinical research for actin-sequestering capabilities and cell migration modulation, operating through pathways distinct from Tα1's receptor-mediated nuclear factor signaling. Similarly, compounds such as BPC-157 are investigated in preclinical models for angiogenic and cell survival pathways, whereas antimicrobial and host-defense signaling peptides like LL-37 interact with cell membranes and endosomal TLRs. Detailed mechanistic profiles for these comparative compounds are archived in our central research hub.

Lyophilized Cake Maintenance and Long-Term Shelf Stability

Unreconstituted, lyophilized Thymosin Alpha-1 in a 20mg vial exhibits high thermodynamic stability when stored under controlled environment conditions. The solid cake should be stored in a freezer setting maintained at -20°C or lower, protected from light exposure, and kept in a desiccated environment to prevent moisture absorption through the stopper.

Under these conditions, lyophilized Tα1 remains stable for up to 24 months from the date of manufacture. Prior to reconstitution, vials removed from freezer storage should be allowed to equilibrate to room temperature inside a laminar flow hood for approximately 30–60 minutes. Opening or piercing cold vials prematurely can cause atmospheric condensation to form inside the glass, initiating immediate peptide hydration and potential localized degradation prior to controlled reconstitution.